Liquid Biopsy Mutation Profiling in Non-Small Cell Lung Cancer

被引：0
|
作者：
Gedvilaite, V. [1 ]
Sestokaite, A. [2 ]
Sabaliauskaite, R. [2 ]
Jarmalaite, S. [2 ]
Cicenas, S. [3 ]
机构：
[1] Natl Canc Inst, Dept Thorac Surg & Oncol, Vilnius, Lithuania
[2] Natl Canc Inst, Genet Diagnost Lab, Vilnius, Lithuania
[3] Vilnius Univ, Fac Med, Clin Internal Dis Family Med & Oncol, Vilnius, Lithuania
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Liquid biopsy; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P02.24
引用
收藏
页码：S256 / S257
页数：2
相关论文
共 50 条
  • [1] Liquid Biopsy in Non-Small Cell Lung Cancer
    Molina-Vila, Miguel A.
    Mayo-de-las-Casas, Clara
    Gimenez-Capitan, Ana
    Jordana-Ariza, Nuria
    Garzon, Monica
    Balada, Ariadna
    Villatoro, Sergi
    Teixido, Cristina
    Garcia-Pelaez, Beatriz
    Aguado, Cristina
    Jose Catalan, Maria
    Campos, Raquel
    Perez-Rosado, Ana
    Bertran-Alamillo, Jordi
    Martinez-Bueno, Alejandro
    Gil, Maria-de-los-Lianos
    Gonzalez-Cao, Maria
    Gonzalez, Xavier
    Morales-Espinosa, Daniela
    Viteri, Santiago
    Karachaliou, Niki
    Rosell, Rafael
    [J]. FRONTIERS IN MEDICINE, 2016, 3
  • [2] The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer
    Ezeife, Doreen A.
    Spackman, Eldon
    Juergens, Rosalyn A.
    Laskin, Janessa J.
    Agulnik, Jason S.
    Hao, Desiree
    Laurie, Scott A.
    Law, Jennifer H.
    Le, Lisa W.
    Kiedrowski, Lesli A.
    Melosky, Barbara
    Shepherd, Frances A.
    Cohen, Victor
    Wheatley-Price, Paul
    Vandermeer, Rachel
    Li, Janice J.
    Fernandes, Roxanne
    Shokoohi, Aria
    Lanman, Richard B.
    Leighl, Natasha B.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [3] The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer
    Ezeife, D.
    Spackman, E.
    Juergens, R.
    Laskin, J.
    Agulnik, J.
    Hao, D.
    Laurie, S.
    Law, J.
    Le, L.
    Kiedrowski, L.
    Melosky, B.
    Shepherd, F. A.
    Cohen, V.
    Wheatley-Price, P.
    Vandermeer, R.
    Li, J.
    Fernandes, R.
    Shokoohi, A.
    Lanman, R.
    Leighl, N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S876 - S876
  • [4] Molecular profiling of non-small cell lung cancer (NSCLC) - the liquid biopsy comes of age
    Pender, A.
    Garcia-Murillas, I.
    de Castro, D. Gonzalez
    Popat, S.
    Downward, J.
    [J]. LUNG CANCER, 2014, 83 : S5 - S5
  • [5] Mutation analysis in liquid biopsy from Lithuanian non-small cell lung cancer patients
    Jarmalaite, S.
    Sestokaite, A.
    Gedvilaite, V.
    Sabaliauskaite, R.
    Cicenas, S.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 542 - 543
  • [6] Biopsy and Mutation Detection Strategies in Non-Small Cell Lung Cancer
    Jung, Chi Young
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2013, 75 (05) : 181 - 187
  • [7] Mutation profiling of non-small cell lung cancer small biopsy samples using mass spectrometry and the SequenomLungCarta Panel
    Quinn, A. M.
    Hickson, N.
    Adaway, M.
    Priest, L.
    Keeling, C.
    Wallace, A.
    Nonaka, D.
    Byers, R.
    Newman, W.
    Blackhall, F. H.
    [J]. LUNG CANCER, 2014, 83 : S9 - S9
  • [8] Liquid biopsy in non-small cell lung cancer: come of age
    Ahn, Myung-Ju
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S629 - S631
  • [9] Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges
    Rijavec, Erika
    Coco, Simona
    Genova, Carlo
    Rossi, Giovanni
    Longo, Luca
    Grossi, Francesco
    [J]. CANCERS, 2020, 12 (01)
  • [10] Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance
    Schwartzberg, Lee S.
    Horinouchi, Hidehito
    Chan, David
    Chernilo, Sara
    Tsai, Michaela L.
    Isla, Dolores
    Escriu, Carles
    Bennett, John P.
    Clark-Langone, Kim
    Svedman, Christer
    Tomasini, Pascale
    [J]. NPJ PRECISION ONCOLOGY, 2020, 4 (01)
12345